240 related articles for article (PubMed ID: 15553107)
21. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
[TBL] [Abstract][Full Text] [Related]
22. The effect of intravenous ketorolac on capsaicin-induced deep tissue hyperalgesia.
Kumar K; Polston GR; Wallace MS
Anesth Analg; 2006 Sep; 103(3):696-702. PubMed ID: 16931683
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of adrenosensitivity in capsaicin induced hyperalgesia.
Schattschneider J; Zum Buttel I; Binder A; Wasner G; Hedderich J; Baron R
Eur J Pain; 2007 Oct; 11(7):756-63. PubMed ID: 17234439
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
[TBL] [Abstract][Full Text] [Related]
25. Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain.
Baad-Hansen L; Juhl GI; Jensen TS; Brandsborg B; Svensson P
Pain; 2007 May; 129(1-2):46-54. PubMed ID: 17088020
[TBL] [Abstract][Full Text] [Related]
26. Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects.
Hoeben E; Smit JW; Upmalis D; Rusch S; Schaffler K; Reitmeir P; Mangold B
Pain; 2012 Aug; 153(8):1648-1656. PubMed ID: 22703892
[TBL] [Abstract][Full Text] [Related]
27. Areas of capsaicin-induced secondary hyperalgesia and allodynia are reduced by a single chiropractic adjustment: a preliminary study.
Mohammadian P; Gonsalves A; Tsai C; Hummel T; Carpenter T
J Manipulative Physiol Ther; 2004; 27(6):381-7. PubMed ID: 15319760
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of capsaicin evoked trigeminal pain on warmth sensation and warmth evoked potentials.
Valeriani M; Tinazzi M; Le Pera D; Restuccia D; De Armas L; Maiese T; Tonali P; Arendt-Nielsen L
Exp Brain Res; 2005 Jan; 160(1):29-37. PubMed ID: 15316704
[TBL] [Abstract][Full Text] [Related]
29. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
30. Plasma levels after peroral and topical ibuprofen and effects upon low pH-induced cutaneous and muscle pain.
Steen AE; Reeh PW; Geisslinger G; Steen KH
Eur J Pain; 2000; 4(2):195-209. PubMed ID: 10957700
[TBL] [Abstract][Full Text] [Related]
31. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans.
Koppert W; Wehrfritz A; Körber N; Sittl R; Albrecht S; Schüttler J; Schmelz M
Pain; 2004 Mar; 108(1-2):148-53. PubMed ID: 15109518
[TBL] [Abstract][Full Text] [Related]
32. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
Sang CN; Hostetter MP; Gracely RH; Chappell AS; Schoepp DD; Lee G; Whitcup S; Caruso R; Max MB
Anesthesiology; 1998 Nov; 89(5):1060-7. PubMed ID: 9821993
[TBL] [Abstract][Full Text] [Related]
33. Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers.
Frymoyer AR; Rowbotham MC; Petersen KL
J Pain; 2007 Jan; 8(1):19-25. PubMed ID: 17113353
[TBL] [Abstract][Full Text] [Related]
34. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain.
Burian M; Tegeder I; Seegel M; Geisslinger G
Clin Pharmacol Ther; 2003 Aug; 74(2):113-20. PubMed ID: 12891221
[TBL] [Abstract][Full Text] [Related]
35. Analgesic efficacy of low doses of intravenously administered lidocaine on experimental laser-induced pain: a placebo controlled study.
Nielsen JC; Arendt-Nielsen L; Bjerring P; Carlsson P
Reg Anesth; 1991; 16(1):28-33. PubMed ID: 2007102
[TBL] [Abstract][Full Text] [Related]
36. Modulation of laser-evoked potentials by experimental cutaneous tonic pain.
Valeriani M; Tonali P; Le Pera D; Restuccia D; De Armas L; Del Vesco C; Miliucci R; Fiaschi A; Vigevano F; Arendt-Nielsen L; Tinazzi M
Neuroscience; 2006 Jul; 140(4):1301-10. PubMed ID: 16626874
[TBL] [Abstract][Full Text] [Related]
37. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.
Koppert W; Ihmsen H; Körber N; Wehrfritz A; Sittl R; Schmelz M; Schüttler J
Pain; 2005 Nov; 118(1-2):15-22. PubMed ID: 16154698
[TBL] [Abstract][Full Text] [Related]
38. Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study.
Wetzel L; Zadrazil M; Paternostro-Sluga T; Authried G; Kozek-Langenecker S; Scharbert G
Eur J Anaesthesiol; 2014 Jan; 31(1):35-40. PubMed ID: 24141646
[TBL] [Abstract][Full Text] [Related]
39. A human model of intraoral pain and heat hyperalgesia.
Baad-Hansen L; Jensen TS; Svensson P
J Orofac Pain; 2003; 17(4):333-40. PubMed ID: 14737878
[TBL] [Abstract][Full Text] [Related]
40. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol.
Singler B; Tröster A; Manering N; Schüttler J; Koppert W
Anesth Analg; 2007 Jun; 104(6):1397-403, table of contents. PubMed ID: 17513631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
